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CASE REPORT
Successful auxiliary two-staged partial 
resection liver transplantation (ASPIRE-LTx) 
for end-stage liver disease to avoid 
small-for-size situations
Stefan M. Brunner1* , Frank W. Brennfleck1, Henrik Junger1, Jirka Grosse3, Birgit Knoppke2, Edward K. Geissler1, 
Michael Melter2 and Hans J. Schlitt1 
Abstract 
Background: Risks for living-liver donors are lower in case of a left liver donation, however, due to lower graft vol-
ume, the risk for small-for-size situations in the recipients increases. This study aims to prevent small-for-size situations 
in recipients using an auxiliary two-staged partial resection liver transplantation (LTX) of living-donated left liver lobes.
Case presentation: Two patients received a two-stage auxiliary LTX using living-donated left liver lobes after left 
lateral liver resection. The native extended right liver was removed in a second operation after sufficient hypertrophy 
of the left liver graft had occurred. Neither donor developed postoperative complications. In both recipients, the graft 
volume increased by an average of 105% (329 ml to 641 ml), from a graft-to-body-weight ratio of 0.54 to 1.08 within 
11 days after LTX, so that the remnant native right liver could be removed. No recipient developed small-for-size syn-
drome; graft function and overall condition is good in both recipients after a follow-up time of 25 months.
Conclusions: Auxiliary two-staged partial resection LTX using living-donor left lobes is technically feasible and can 
prevent small-for-size situation. This new technique can expand the potential living-donor pool and contributes to 
increase donor safety.
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Background
For some patients living-donor liver transplantation 
(LTX) remains the only treatment option for end-stage 
liver disease [1]. Donor safety must be considered in 
this setting [2]. One option to increase donor safety in 
adult-to-adult living donor LTX is using only either the 
left or left-lateral liver lobe for transplantation. In this 
case, risks for recipients significantly increase, mostly 
due to an increased chance for small-for-size syndrome 
and hepatic artery thrombosis which are associated with 
a graft-to-body-weight ratio < 0.6%, resulting in 1  year 
graft survival rates < 60% [2]. To overcome this problem, 
we aimed to investigate the safety and feasibility of liver 
hypertrophy techniques known from ALLPS procedure 
combined with an auxiliary LTX in a two-stage concept, 
which is technically demanding, but shifts potential risks 
from the donor towards the recipient [3].
Case presentation
Methods
In the donors, a standard left liver resection (segment I, 
II, IV) using crush-clamp technique with bipolar sealing 
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and clipping of larger structures was performed. The left 
hepatic artery, the portal vein and middle and left hepatic 
vein were sutured and cut. The graft was flushed with 
heparin immediately and perfused with HTK solution via 
the portal vein.
In the recipients, after liver mobilization and chole-
cystectomy, the liver hilum was dissected, and the main 
portal vein and left liver artery were isolated; then, the 
left-lateral liver was resected. The left portal vein and 
bile duct were sutured and cut, and the left hepatic vein 
clamped. The vena cava was dissected around the left 
hepatic vein orifice, so that an incision could be made 
from the left vein into the vena cava after clamping to 
enable a wide venous anastomosis.
In the graft, the left and middle donor veins were 
sutured together to receive a common ostium. The 
venous and subsequent portal anastomosis (E/E) was 
performed. After reperfusion, the donor artery was anas-
tomosed onto the left recipient liver artery (E/E). The 
biliodigestive anastomosis was performed during the 
planned relaparotomy. During hepatectomy completion, 
the liver was mobilized from the vena cava, and the right 
hilar structures and right and middle hepatic veins were 
dissected and cut between sutures.
Donors and recipients were evaluated using CT and 
MRI scans with arterial and portovenous contrast phases 
and additionally MRCP scans for evaluation of bile duct 
anatomy. Preoperative volumes for left and right liver 
lobes and whole liver after hypertrophy at postoperative 
day 10–12 were calculated from CT scans. Furthermore, 
99mTc-mebrofenin hepatobiliary scintigraphy (HBS) scans 
were performed at postoperative day 1 and 10 to monitor 
future graft function, and liver perfusion was assessed by 
duplex and contrast enhanced ultrasound [4–6].
Case 1
Recipient 1, a 30 years-old female with overlap syndrome 
of autoimmune hepatitis Type 1, primary sclerosing 
cholangitis and severe portal hypertension, received a 
324  cm3 graft (graft-to-body-weight ratio 0.65%; Fig. 1a) 
with two arteries, one for liver segment IV from the 
standard left artery and one accessory left for segments 
II/III; these arteries were reconstructed into one anas-
tomosis. The portal vein was anastomosed to the distal 
left portal vein (E/E to a segment III branch). Since por-
tal vein pressure measurement detected hyperperfusion 
(18–20  mmHg), the splenic artery was ligated, which 
reduced portovenous pressure (12 mmHg). Due to insta-
ble positioning, the liver was packed and biliodigestive 
anastomosis was not directly performed. Two days later 
during the next look operation, a biliodigestive anasto-
mosis was performed with an Roux-en-Y jejunal loop. 
After graft hypertrophy (81%; Figs.  1b, 3), the patient 
was reoperated at postoperative day (POD) 14 and the 
remaining native right liver including segment one was 
resected. Due to traction during this operation, the bili-
odigestive anastomosis became dehiscent and was rean-
astomosed. Due to reduced arterial perfusion in segment 
II/III in duplex ultrasound controls and a stenosis at the 
arterial anastomosis (CT scan), the arterial anastomo-
sis was dilated angiographically on POD 17. Since the 
patient developed 2  l ascites per day beginning at POD 
Fig. 1 Preoperative CT scan of donor 1. a Volumetry of liver segment II/III (209  cm3), segment IV (115  cm3), segment I (19  cm3) and segments V–VIII 
(1227  cm3). b CT scan of recipient 1 at postoperative day 12 (before removal of the native right liver) with volumetry of the graft (587  cm3) after 
hypertrophy
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20, another CT scan was performed showing a kink-
ing and stenosis of the left hepatic venous anastomosis, 
possibly due to liver hyperthrophy and positioning. Con-
sequently, angioplasty with left liver vein stenting was 
necessary; thereafter, aspirin 100  mg/day was adminis-
tered. Six weeks after LTX, remaining drains showed bil-
iary secretion so that a PTCD was placed which showed 
a partial biliary leakage at the biliodigestive anastomosis; 
the leakage stopped 6 days after PTCD treatment. Con-
secutively, ascites production decreased, all drains could 
be removed, and the patient was discharged in good 
condition 8  weeks after LTX; the PTCD was removed 
3 months post-implantation.
One year after LTX an anastomotic portal vein stenosis 
developed, with the patient receiving a transhepatic angi-
oplasty and portal vein stent (uncovered, self-expanding) 
during a 1-day hospital admission. Until now (2½ years 
post-LTX) liver function has been good (normal labora-
tory values) and the patient is back to work and taking 
care of her child.
Case 2
Recipient 2, a 16  year-old male with congenital liver 
fibrosis, consecutive cirrhosis and severe portal hyper-
tension, received a 303   cm3 graft (graft-to-body-weight 
ratio 0.43%; Fig. 2a) also with two separately anastomosed 
arteries. The portal vein was anastomosed E/S to the por-
tal vein main stem. Due to portal hypertension and sple-
nomegaly, a simultaneous splenectomy was performed. 
The biliodigestive anastomosis was not performed dur-
ing the first operation (bile duct drained externally via 
a small luminal bile duct catheter) with local packing. 
During the planned second look operation at POD 1, a 
portal vein thrombosis was detected without kinking or 
detection of anastomotic problems. The thrombus was 
surgically removed through a portal vein incision, with 
a catheter placed for 48  h Alteplase lysis therapy into a 
mesenteric vein branch; no further sign of thrombosis 
were detected by duplex ultrasound controls. This cath-
eter was removed at POD 3 and a biliodigestive anas-
tomosis was sutured using an Rouy-en-Y jejunal loop. 
After graft hypertrophy (129%; Figs. 2b, 3), the remaining 
native liver was removed without complications at POD 
10.
Recipient 2 had an uneventful course after discharge 
(5  weeks after LTX), with a mild cellular rejection epi-
sode 1 year after LTX. Duplex ultrasounds showed nor-
mal liver graft perfusion and no signs of fibrosis. Liver 
function is good and the patient currently attends school 
now 20 months post-LTX.
Both donors had an uncomplicated intra- and post-
operative course, were discharged in good condition at 
postoperative day 7–8, and had no medical problems fol-
lowing living donation.
Discussion and conclusions
We describe a new treatment concept for patients with 
end-stage liver disease in whom a living-donor left liver 
lobe is used in an auxiliary two-stage LTX setting to avoid 
a potential small-for-size situation. Our approach uses a 
left liver lobe instead of a left-lateral lobe in an auxiliary 
setting in cirrhotic patients. Here, we show the method 
is feasible and can be performed safely and successfully, 
at least in the first two patients. This is in contrast to a 
Fig. 2 Preoperative CT scan of donor 2. a Volumetry of liver segment II/III (303  cm3) and segments V–VIII (1277  cm3). b CT scan of recipient 2 at 
postoperative day 10 (before removal of the native right liver) with volumetry of the graft (694  cm3) after hypertrophy
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study that also described a treatment concept for cirrho-
sis where two recipients after left-lateral liver resection 
then received auxillary LTX using left-lateral grafts [7]. 
After graft hypertrophy, in one patient the procedure was 
completed by resection of the native liver, but the other 
patient required retransplantation [7].
Similar approaches were undertaken in the treatment 
of irresectable colorectal liver metastases but for non-cir-
rhotic livers. In this setting, after left hepatectomy, a right 
portal vein ligation was performed, followed by trans-
plantation of a living-donated left-lateral liver lobe as 
auxiliary partial orthotopic LTX followed by completion 
hepatectomy 2 weeks later [8]. In contrast to our study, 
this concept is performed in a non-cirrhotic liver [8, 9]. 
This enables the surgeon to perform the necessary left 
hepatectomy and, additionally, a right portal vein ligation 
to enhance graft hypertrophy. In our study, the recipients 
already suffered from severe portal hypertension with 
massive splenomegaly (invasively measured portovenous 
pressure 18–20 mmHg). Therefore, it was not necessary 
and possible to ligate the right portal vein. In contrast, we 
were even forced, to reduce portal vein pressure.
Generally, management of portal vein perfusion is 
important to prevent small-for-size-syndrome with 
rather small liver grafts [10, 11]. Hemiportocaval shunt is 
one possible solution, splenectomy or splenic artery liga-
tion are others [11–13]. In the situation of a temporar-
ily remaining native right liver where a hemiportocaval 
shunt is complicated, we decided for splenectomy in one 
recipient and splenic artery ligation in the other, which 
is also known to be an effective method to avoid portal 
hyperperfusion and was successful in our recipients (por-
tovenous pressure 6–8 mm Hg) [12, 13].
Multiple complications occurred in these cases. We 
had to deal with arterial stenosis, portal vein thrombosis, 
biliary leakage, venous outflow obstruction due to graft 
Fig. 3 Postoperative course of recipients` graft volume and function. Development of a graft volume and b graft function calculated from 
hepatobiliary scintigraphy (HBS) at baseline (transplantation) and before completion hepatectomy. Summed HBS images after i.v. injection of 
99mTc-mebrofenin and corresponding time-activity curve of c recipient 1 at transplantation and d before removal of the native right liver and e 
recipient 2 at transplantation and f before removal of the native right liver. Regions of interest were drawn around the native liver and liver graft (red 
line), the liver graft alone (yellow line) and the heart defined as blood pool (green line). The second green line represents the blood pool fit; the blue 
line shows the total counts
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hypertrophy and portal vein stenosis in the long-term 
follow-up. If complications do occur, “hypersmall” left-
lateral liver grafts as used in one of the described studies 
are at high risk of liver failure due to lacking functional 
reserve [3]. Instead, we used left liver lobes (liver seg-
ments II/III/IV) with slightly higher graft volume. This 
graft-size optimization strategy is a reasonable explana-
tion why our recipients could safely undergo comple-
tion hepatectomy after an average of 12 days, facilitating 
long-term graft and patient survival in spite of several 
complications.
Decide on timing of completion hepatectomy is dif-
ficult. For this decision we used CT-volumetric meas-
urements and hepatobiliary scintigraphy together with 
regular laboratory parameters. While CT volumetry is an 
established method to quantify liver hypertrophy, hepa-
tobiliary scintigraphy adds a functional parameter to 
simple volume measurement, but has not been routinely 
used in the setting of LTX or liver hyperthrophy. We sug-
gest that this method needs to be critically evaluated 
further. While, in principal, the longer it is possible to 
wait, the better the liver hypertrophy will be, this must be 
balanced against potential increasing surgical problems 
regarding adhesions and reduced intraabdominal space. 
After this two case experience, we consider 10–12  days 
after the initial operative step as the best timing for com-
pleting hepatectomy with sufficient time for graft hyper-
trophy [3].
Taking our complications into consideration—after this 
two case experience—our “optimized” technical approach 
would first be to anastomose the portal vein to the recipi-
ents’ main portal trunk, since this reconstruction is more 
stable with regard to positioning of the liver and not 
overly long after removal of the native liver. Second, we 
suggest resecting liver segment I in the recipient during 
the first operative step, providing an easier approach dur-
ing the completion operation resulting in less manipula-
tion of the transplanted graft. Third, we suggest a second 
look operation at POD 1 and delay of the biliodigestive 
anastomosis to this time point; this approach is meant to 
increase patient and graft safety by directly evaluating the 
graft, with assurance of optimal blood in- and outflow. 
Moreover, this step provides an important opportunity to 
further position the graft, which can change dramatically 
after completion hepatectomy.
In conclusion, these cases demonstrate that living-
donor left lobe auxiliary two-stage LTX to avoid small-
for-size situation in adults/adolescents is safe and 
technically feasible. This new technique could expand 
the potential living-donor pool, and in selected recipient/
donor combinations enables a living liver donation and 
additionally contributes to increase donor safety.
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